FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cyclosporine Capsules
Status: Discontinuation
»Therapeutic Categories: Dermatology; Pediatric; Rheumatology; Transplant

Expand all

Sandoz (New 05/10/2016)

Company Contact Information:
1-800-525-8747

Presentation Posting Date Related Information
Cyclosporine Capsules USP 25mg (NDC 0185-0932-30) 05/10/2016 Sandoz Inc. has made a business decision to permanently discontinue Cyclosporine 25mg and 100mg capsules. This decision was not related to efficacy, safety, or quality. Manufacturing will be discontinued no later than September 30, 2016, and we anticipant supply availability on the US market until Q1 2017.
Cyclosporine Capsules USP 100mg (NDC 0185-0933-30) 05/10/2016 Sandoz Inc. has made a business decision to permanently discontinue Cyclosporine 25mg and 100mg capsules. This decision was not related to efficacy, safety, or quality. Manufacturing will be discontinued no later than September 30, 2016, and we anticipant supply availability on the US market until Q1 2017.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English